Borosil Scientific to shift unit at Ambad to Bharuch
This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials
This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine
At the recommended Phase 3 dose of 200 mg vepdegestrant in combination with palbociclib, patients achieved a median progression-free survival of 13.9 months
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Minister was briefed on the nationwide dengue situation
Subscribe To Our Newsletter & Stay Updated